EnteroMedics raises about $12 million for obesity device

03/5/2013 | MassDevice.com (Boston)

EnteroMedics has raised net proceeds of about $12 million in a public offering. The St. Paul, Minn.-based company will use the money to seek FDA approval for its Maestro RC system, which uses vagal nerve blocking to help treat patients with obesity, as well as to market the product outside the U.S.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY